Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
2.970
+0.180 (6.45%)
May 28, 2026, 4:00 PM EDT - Market closed
Exicure Market Cap
Exicure has a market cap or net worth of $18.93 million as of May 28, 2026. Its market cap has decreased by -74.73% in one year.
Market Cap
18.93M
Enterprise Value
14.21M
1-Year Change
-74.73%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.30M to $18.93M, a decrease of -84.52%. That is a compound annual growth rate of -20.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 17.80M | -48.41% |
| Dec 31, 2025 | 34.50M | 16.16% |
| Dec 31, 2024 | 29.70M | 494.00% |
| Dec 29, 2023 | 5.00M | -12.28% |
| Dec 30, 2022 | 5.70M | -67.98% |
| Dec 31, 2021 | 17.80M | -88.47% |
| Dec 31, 2020 | 154.40M | -28.95% |
| Dec 31, 2019 | 217.30M | 42.03% |
| Dec 31, 2018 | 153.00M | 25.10% |
| May 22, 2018 | 122.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 19.07M |
| NewcelX | 18.74M |
| AEON Biopharma | 18.71M |
| Passage Bio | 18.24M |
| Lipocine | 18.14M |
| Citius Pharmaceuticals | 17.85M |
| IN8bio | 17.43M |
| BiomX | 16.69M |